----

| Cayman Islands(State or other jurisdiction ofincorporation or organization)               |   | 98-1593951(I.R.S. Employer Identification Number) |
|-------------------------------------------------------------------------------------------|--------|---------------------------------------------------|
|                                                                                      |   |                                              |
| 2 Wisconsin Circle,7th FloorChevy Chase, MD 20815(Address of principal executive offices) |   | 20815(Zip Code)                                   |
| Title of each class                                                                                                                  |   | Trading Symbol(s) |   | Name of each exchangeon which registered |
|--------------------------------------------------------------------------------------------------------------------------------------|--------|-------------------|--------|------------------------------------------|
| Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant to purchase one Class A ordinary share   |   | BOCNU             |   | The Nasdaq Stock Market LLC              |
| Class A ordinary share, par value $0.0001 per share                                                                                  |   | BOCN              |   | The Nasdaq Stock Market LLC              |
| Redeemable warrants, each exercisable for one Class A ordinary share at an exercise price of $11.50 per share, subject to adjustment |   | BOCNW             |   | The Nasdaq Stock Market LLC              |

----

----

| Large accelerated filer ☐ | Accelerated filer ☐ | Non-accelerated filer ☒ | Smaller reporting company ☒ |
|---------------------------------|---------------------------|-------------------------------|-----------------------------------|
|                            |                      |                          | Emerging growth company ☒   |

----

| Cautionary Note Regarding Forward-Looking Statements                                                                             | 2  |
|----------------------------------------------------------------------------------------------------------------------------------|----|
| Item1 Business.                                                                                                                  | 3  |
| Item 1A Risk Factors.                                                                                                            | 12 |
| Item 1B. Unresolved Staff Comments.                                                                                              | 48 |
| Item 2. Properties.                                                                                                              | 48 |
| Item 3. Legal Proceedings.                                                                                                       | 48 |
| Item 4. Mine Safety Disclosures.                                                                                                 | 48 |
| Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. | 49 |
| Item 6. Reserved                                                                                                            | 50 |
| Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.                        | 50 |
| Item 7A. Quantitative and Qualitative Disclosures About Market Risk.                                                        | 54 |
| Item 8. Financial Statements and Supplementary Data.                                                                        | 54 |
| Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure.                               | 54 |
| Item 9A. Controls and Procedures.                                                                                           | 54 |
| Item 9B. Other Information.                                                                                                 | 55 |
| Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections .                                              | 55 |
| Item 10. Directors, Executive Officers and Corporate Governance.                                                            | 56 |
| Item 11. Executive Compensation.                                                                                            | 62 |
| Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.                    | 63 |
| Item 13. Certain Relationships and Related Transactions, and Director Independence.                                         | 65 |
| Item 14. Principal Accountant Fees and Services.                                                                            | 68 |
| Item 15. Exhibits and Financial Statement Schedules.                                                                        | 69 |
| Item 16. Form 10-K Summary.                                                                                                 | 71 |
| Index to Financial Statements                                                                                                    | 72 |

----

 Table of Contents

|  | • | our ability to select an appropriate target business or businesses; |
|--|---------|---------------------------------------------------------------------|
|  | • | our ability to complete our initial business combination; |
|--|---------|-----------------------------------------------------------|
|  | • | our expectations around the performance of a prospective target business or businesses; |
|--|---------|-----------------------------------------------------------------------------------------|
|  | • | our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination; |
|--|---------|------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination; |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | our potential ability to obtain additional financing to complete our initial business combination; |
|--|---------|----------------------------------------------------------------------------------------------------|
|  | • | our pool of prospective target businesses; |
|--|---------|--------------------------------------------|
|  | • | our ability to consummate an initial business combination due to the uncertainty resulting from the COVID-19 pandemic and other events (such as terrorist attacks, natural disasters or a significant outbreak of other infectious diseases); |
|--|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | the ability of our officers and directors to generate a number of potential business combination opportunities; |
|--|---------|-----------------------------------------------------------------------------------------------------------------|
|  | • | our public securities’ potential liquidity and trading; |
|--|---------|---------------------------------------------------------------|
|  | • | the lack of a market for our securities; |
|--|---------|------------------------------------------|
|  | • | the use of proceeds not held in the Trust Account (defined below) or available to us from interest income on the Trust Account balance; |
|--|---------|-----------------------------------------------------------------------------------------------------------------------------------------|
|  | • | the Trust Account not being subject to claims of third parties; or |
|--|---------|--------------------------------------------------------------------|
|  | • | our financial performance. |
|--|---------|----------------------------|

----

 Table of Contents

| Item 1. | Business. |
|---------|-----------|

----

 Table of Contents

----

 Table of Contents

----

 Table of Contents

----

 Table of Contents

----

 Table of Contents

|  | • | conduct the redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of the Exchange Act, which regulates the solicitation of proxies, and not pursuant to tender offer rules; and |
|--|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | file proxy materials with the SEC. |
|--|---------|------------------------------------|
|  | • | conduct the redemptions pursuant to Rule 13e- 4 and Regulation 14E of the Exchange Act, which regulate issuer tender offers; and |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------------|
|  | • | file tender offer documents with the SEC prior to completing our initial business combination which contain substantially the same financial and other information about the initial business combination and the redemption rights as is              required under Regulation 14A of the Exchange Act, which regulates the solicitation of proxies. |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

 Table of Contents

----

 Table of Contents

----

 Table of Contents

----

 Table of Contents

| Item 1A. | Risk Factors. |
|----------|---------------|

----

 Table of Contents

----

 Table of Contents

----

 Table of Contents

----

 Table of Contents

----

 Table of Contents

----

 Table of Contents

|  | • | a limited availability of market quotations for our securities; |
|--|---------|----------------------------------------------------------------------|
|  | • | reduced liquidity for our securities; |
|--|---------|--------------------------------------------|
|  | • | a determination that our Class A ordinary shares are a “penny stock” which will require brokers trading in our Class A ordinary shares to adhere to more stringent rules and possibly result in a reduced level of trading activity in the              secondary trading market for our securities; |
|--|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | a limited amount of news and analyst coverage; and |
|--|---------|---------------------------------------------------------|
|  | • | a decreased ability to issue additional securities or obtain additional financing in the future. |
|--|---------|--------------------------------------------------------------------------------------------------|

----

 Table of Contents

----

 Table of Contents

----

 Table of Contents

----

 Table of Contents

----

 Table of Contents

----

 Table of Contents

----

 Table of Contents

----

 Table of Contents

----

 Table of Contents

|  | • | solely dependent upon the performance of a single business, property or asset; or |
|--|---------|----------------------------------------------------------------------------------------|
|  | • | dependent upon the development or market acceptance of a single or limited number of products, processes or services. |
|--|---------|-----------------------------------------------------------------------------------------------------------------------|

----

 Table of Contents

----

 Table of Contents

|   | (i) | we issue additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of our initial business combination at a newly issued price (such issue price or effective issue price to be                  determined in good faith by our board of directors and, in the case of any issuance to our sponsor, Apollo or their affiliates, without taking into account any founder shares held by our sponsor, Apollo or such affiliates, as applicable,                  prior to such issuance) (the “Newly Issued Price”) of less than $9.20 per ordinary share; |
|--------|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (ii) | the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of our initial business combination on the date of the completion of our initial              business combination (net of redemptions); and |
|--|------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | (iii) | the volume weighted average trading price of our Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which we consummate our initial business combination (such price, the “Market Value”)              is below $9.20 per share, |
|--|-------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

 Table of Contents

|  | • | costs and difficulties inherent in managing cross-border business operations; |
|--|---------|------------------------------------------------------------------------------------|
|  | • | rules and regulations regarding currency redemption; |
|--|---------|-----------------------------------------------------------|
|  | • | complex corporate withholding taxes on individuals; |
|--|---------|----------------------------------------------------------|
|  | • | laws governing the manner in which future business combinations may be effected; |
|--|---------|---------------------------------------------------------------------------------------|
|  | • | exchange listing and/or delisting requirements; |
|--|---------|------------------------------------------------------|
|  | • | tariffs and trade barriers; |
|--|---------|----------------------------------|
|  | • | regulations related to customs and import/export matters; |
|--|---------|----------------------------------------------------------------|
|  | • | local or regional economic policies and market conditions; |
|--|---------|-----------------------------------------------------------------|
|  | • | unexpected changes in regulatory requirements; |
|--|---------|-----------------------------------------------------|
|  | • | challenges in managing and staffing international operations; |
|--|---------|--------------------------------------------------------------------|
|  | • | longer payment cycles; |
|--|---------|-----------------------------|

----

 Table of Contents

|  | • | tax issues, such as tax law changes and variations in tax laws as compared to the United States; |
|--|---------|-------------------------------------------------------------------------------------------------------|
|  | • | currency fluctuations and exchange controls; |
|--|---------|---------------------------------------------------|
|  | • | rates of inflation; |
|--|---------|--------------------------|
|  | • | challenges in collecting accounts receivable; |
|--|---------|----------------------------------------------------|
|  | • | cultural and language differences; |
|--|---------|-----------------------------------------|
|  | • | employment regulations; |
|--|---------|------------------------------|
|  | • | underdeveloped or unpredictable legal or regulatory systems; |
|--|---------|-------------------------------------------------------------------|
|  | • | corruption; |
|--|---------|------------------|
|  | • | protection of intellectual property; |
|--|---------|-------------------------------------------|
|  | • | social unrest, crime, strikes, riots, civil disturbances and wars; |
|--|---------|-------------------------------------------------------------------------|
|  | • | regime changes and political upheaval; and |
|--|---------|-------------------------------------------------|
|  | • | deterioration of political relations with the United States. |
|--|---------|--------------------------------------------------------------|
|  | • | restrictions on the nature of our investments; and |
|--|---------|---------------------------------------------------------|
|  | • | restrictions on the issuance of securities; |
|--|---------|---------------------------------------------|
|  | • | registration as an investment company with the SEC; |
|--|---------|----------------------------------------------------------|
|  | • | adoption of a specific form of corporate structure; and |
|--|---------|--------------------------------------------------------------|
|  | • | reporting, record keeping, voting, proxy and disclosure requirements and other rules and regulations that we are currently not subject to. |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------------|

----

 Table of Contents

----

 Table of Contents

----

 Table of Contents

----

 Table of Contents

----

 Table of Contents

|  | • | may significantly dilute the equity interest of public shareholders, which dilution would increase if the anti-dilution provisions in the Class B ordinary shares resulted in the issuance of Class A ordinary shares on a greater than              one-to-one basis upon conversion of the Class B ordinary shares; |
|--|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | may subordinate the rights of holders of Class A ordinary shares if preference shares are issued with rights senior to those afforded our Class A ordinary shares; |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | could cause a change in control if a substantial number of Class A ordinary shares are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or              removal of our present officers and directors; |
|--|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | may have the effect of delaying or preventing a change of control of us by diluting the share ownership or voting rights of a person seeking to obtain control of us; |
|--|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | may adversely affect prevailing market prices for our Units, Class A ordinary shares and/or warrants; and |
|--|---------|----------------------------------------------------------------------------------------------------------------|
|  | • | may not result in adjustment to the exercise price of our warrants. |
|--|---------|---------------------------------------------------------------------|

----

 Table of Contents

----

 Table of Contents

|  | • | default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations; |
|--|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

 Table of Contents

|  | • | acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or              renegotiation of that covenant; |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | our immediate payment of all principal and accrued interest, if any, if the debt is payable on demand; |
|--|---------|-------------------------------------------------------------------------------------------------------------|
|  | • | our inability to obtain necessary additional financing if the debt contains covenants restricting |
|--|---------|---------------------------------------------------------------------------------------------------|
|  | • | our ability to obtain such financing while the debt is outstanding; |
|--|---------|--------------------------------------------------------------------------|
|  | • | our inability to pay dividends on our Class A ordinary shares; |
|--|---------|---------------------------------------------------------------------|
|  | • | using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our Class A ordinary shares if declared, expenses, capital expenditures, acquisitions and other              general corporate purposes; |
|--|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate; |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------|
|  | • | increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation or prevailing interest rates; and |
|--|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who have              less debt. |
|--|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

 Table of Contents

----

 Table of Contents

----

 Table of Contents

----

 Table of Contents

----

 Table of Contents

----

 Table of Contents

----

 Table of Contents

----

 Table of Contents

|  | • | we have a board that includes a majority of “independent directors,” as defined under Nasdaq rules; |
|--|---------|----------------------------------------------------------------------------------------------------------------------|
|  | • | we have a compensation committee of our board that is comprised entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities; and |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | we have independent director oversight of our director nominations. |
|--|---------|---------------------------------------------------------------------|

----

 Table of Contents

| Item 1B. | Unresolved Staff Comments. |
|----------|----------------------------|

| Item 2. | Properties. |
|---------|-------------|

| Item 3. | Legal Proceedings. |
|---------|--------------------|

| Item 4. | Mine Safety Disclosures. |
|---------|--------------------------|

----

 Table of Contents

| Item 5. | Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. |
|---------|---------------------------------------------------------------------------------------------------------------------|

----

 Table of Contents

| Item 6. | Reserved. |
|---------|-----------|

| Item 7. | Management’s Discussion and Analysis of Financial Condition and Results of Operations. |
|---------|----------------------------------------------------------------------------------------------|

----

 Table of Contents

----

 Table of Contents

----

 Table of Contents

----

 Table of Contents

| Item 7A. | Quantitative and Qualitative Disclosures About Market Risk. |
|----------|-------------------------------------------------------------|

| Item 8. | Financial Statements and Supplementary Data. |
|---------|----------------------------------------------|

| Item 9. | Changes in and Disagreements With Accountants on Accounting and Financial Disclosure. |
|---------|---------------------------------------------------------------------------------------|

| Item 9A. | Controls and Procedures. |
|----------|--------------------------|

----

 Table of Contents

| Item 9B. | Other Information. |
|----------|--------------------|

| Item 9C. | Disclosure Regarding Foreign Jurisdictions that Prevent Inspections |
|----------|---------------------------------------------------------------------|

----

 Table of Contents

| Item 10. | Directors, Executive Officers and Corporate Governance. |
|----------|---------------------------------------------------------|

| Name              |   | Age |   | Title                                                        |
|-------------------|--------|-----|--------|--------------------------------------------------------------|
| Marcus Brauchli   |   | 60  |   | Chairman                                                     |
| Paul Bascobert    |   | 57  |   | Chief Executive Officer and Director                         |
| Ankur Manglik     |   | 45  |   | Chief Strategy Officer, Chief Financial Officer and Director |
| Sean Glodek       |   | 50  |   | Vice President and Director                                  |
| Norman Pearlstine |   | 79  |   | Independent Director                                         |
| Joel Motley       |   | 69  |   | Independent Director                                         |
| Matt Goldberg     |   | 51  |   | Independent Director                                         |
| Priscilla Han     |   | 38  |   | Independent Director                                         |
| Dale Mathias      |   | 70  |   | Independent Director                                         |

----

 Table of Contents

----

 Table of Contents

----

 Table of Contents

----

 Table of Contents

----

 Table of Contents

|  | • | the integrity of our financial statements; |
|--|---------|-------------------------------------------------|
|  | • | our compliance with legal and regulatory requirements; |
|--|---------|-------------------------------------------------------------|
|  | • | the qualifications, engagement, compensation, independence and performance of our independent registered public accounting firm; |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------------|
|  | • | our process relating to risk management and the conduct and systems of internal control over financial reporting and disclosure controls and procedures; and |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | the performance of our internal audit function. |
|--|---------|-------------------------------------------------|
|  | • | determining and approving the compensation of our executive officers; and |
|--|---------|--------------------------------------------------------------------------------|
|  | • | reviewing and approving incentive compensation and equity compensation policies and programs. |
|--|---------|-----------------------------------------------------------------------------------------------|

----

 Table of Contents

| Item 11. | Executive Compensation. |
|----------|-------------------------|

----

 Table of Contents

| Item 12. | Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters. |
|----------|-------------------------------------------------------------------------------------------------|

|  | • | each person known by us to be the beneficial owner of more than 5% of our issued outstanding ordinary shares; |
|--|---------|--------------------------------------------------------------------------------------------------------------------|
|  | • | each of our executive officers and directors; and |
|--|---------|--------------------------------------------------------|
|  | • | all our executive officers and directors as a group. |
|--|---------|------------------------------------------------------|
| Name and address of beneficial owner(2)                         |   | Number ofshares ofordinarysharesbeneficiallyowned(4) |      |      | Approximatepercentage ofoutstandingordinaryshares(1) |   |
|-----------------------------------------------------------------|--------|------------------------------------------------------|-----------|-----------|------------------------------------------------------|--------|
| Blue Ocean Sponsor LLC(3)                                       |   |                                                 | 4,328,750 |      |                                                 |   | 18.6 | % |
| Marcus Brauchli(3)                                              |   |                                                 | 4,328,750 |      |                                                 |   | 18.6 | % |
| Paul Bascobert(3)                                               |   |                                                 | 4,328,750 |      |                                                 |   | 18.6 | % |
| Ankur Manglik                                                   |   |                                                 | -         |      |                                                 |   | * |   |
| Sean Glodek(5)                                                  |   |                                                 | -         |      |                                                 |   | * |   |
| Norman Pearlstine                                               |   |                                                 | 25,000    |      |                                                 |   | * |   |
| Joel Motley                                                     |   |                                                 | 30,000    |      |                                                 |   | * |   |
| Matt Goldberg                                                   |   |                                                 | 30,000    |      |                                                 |   | * |   |
| Priscilla Han                                                   |   |                                                 | 30,000    |      |                                                 |   | * |   |
| Dale Mathias                                                    |   |                                                 | 25,000    |      |                                                 |   | * |   |
| All directors and executive officers as a group (9 individuals) |   |                                                 | 4,468,750 |      |                                                 |   | 18.9 | % |
|                                                            |   |                                                 |      |      |                                                 |   |   |   |
| Other 5% Stockholders(6)                                        |   |                                                 |      |      |                                                 |   |   |   |
| Apollo SPAC Fund I, L.P.                                        |   |                                                 | 2,070,602 | (7)  |                                                 |   | 8.9 | % |
| Calamos Market Neutral Income Fund                              |   |                                                 | 1,250,000 | (8)  |                                                 |   | 6.6 | % |
| Highbridge Capital Management, LLC                              |   |                                                 | 1,172,601 | (9)  |                                                 |   | 6.18 | % |
| *      | Less than one percent. |
|-----------------------|------------------------|
| (1) | Based on 23,718,750 ordinary shares outstanding as of March 25, 2022, including 18,975,000 Class A ordinary shares (including those Class A ordinary shares comprising a portion of a Unit) and 4,743,750 Class B ordinary shares. Ordinary              shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Only holders of Class B ordinary shares will have the right to elect all of our directors prior to the consummation of our              initial business combination. |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2) | Unless otherwise noted, the business address of each of our shareholders is 2 Wisconsin Circle, 7th Floor, Chevy Chase, MD 20815. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------|
| (3) | Interests shown consist solely of founder shares, classified as Class B ordinary shares. Such shares will automatically convert into Class A ordinary shares concurrently with or immediately following the consummation of our initial              business combination, or earlier at the option of the holder thereof. |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (4) | Blue Ocean Sponsor LLC is the record holder of the shares reported herein. Each of Marcus Brauchli and Paul Bascobert are the managers of Blue Ocean Sponsor LLC. As such, each of Marcus Brauchli and Paul Bascobert may be deemed to have              beneficial ownership of the Class B ordinary shares held directly by Blue Ocean Sponsor LLC. Each of Marcus Brauchli and Paul Bascobert disclaim beneficial ownership over any securities owned by our sponsor in which he does not have any              pecuniary interest. |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (5) | Does not include any shares indirectly owned by this individual as a result of his or her partnership interest in our sponsor or its affiliates. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------|
| (6) | Interests shown consist of Class A ordinary shares. |
|-----|-----------------------------------------------------|
| (7) | Based upon its Schedule 13G filed December 17, 2021, with the SEC with respect to Class A ordinary shares held as of December 7, 2021, Apollo has shared voting and dispositive power as to 2,070,602 Class A ordinary shares and each of              Apollo SPAC Management I GP, LLC, the general partner of Apollo SPAC Management I, L.P., Apollo Capital Management I, L.P., the investment manager for Apollo, Apollo Capital Management GP, LLC, the general partner of Apollo Capital              Management, L.P. and Apollo Management Holdings, L.P., the sole member and manager of Apollo Capital Management GP, LLC., also have shared voting and dispositive power as to 2,070,602 Class A ordinary shares held by Apollo. |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (8) | Based upon its Schedule 13G filed February 8,2022, with the SEC with respect to Class A ordinary shares held as of December 31, 2021, Calamos Market Neutral Income has sole voting and dispositive power as to 1,250,000 Class A ordinary                shares. |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (9) | Based upon its Schedule 13G filed December 17, 2021, with the SEC with respect to Class A ordinary shares held as of December 7, 2021, Highbridge Capital Management, LLC has shared voting and dispositive power as to 1,172,601 Class A              ordinary shares and each of Highbridge Tactical Credit Master Fund, L.P. and Highbridge SPAC Opportunity Fund, L.P. also have shared voting and dispositive power as to 1,172,601 Class A ordinary shares held by Highbridge Capital Management,              LLC. |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

 Table of Contents

----

 Table of Contents

| Item 13. | Certain Relationships and Related Transactions, and Director Independence. |
|----------|----------------------------------------------------------------------------|

----

 Table of Contents

----

 Table of Contents

----

 Table of Contents

| Item 14. | Principal Accountant Fees and Services. |
|----------|-----------------------------------------|

| Type of Fee        |   | Year EndedDecember 31, 2021 |   |
|--------------------|--------|-----------------------------|--------|
| Audit Fees         |   | $                           | 83,730 |  |
| Audit-Related Fees |   |                        |   |   |
| Tax Fees           |   |                        |   |   |
| All Other Fees     |   |                        |   |   |

----

 Table of Contents

| Item 15. | Exhibits and Financial Statement Schedules. |
|----------|---------------------------------------------|

| (a) | The following documents are filed as part of this report: |
|-----|-----------------------------------------------------------|

|   | (1) | Financial Statements |
|--------|-----|----------------------|

|   | (2) | Financial Statements Schedules |
|--------|-----|--------------------------------|

|   | (3) | Exhibits |
|--------|-----|----------|

----

 Table of Contents

| EXHIBIT INDEX |
|---------------|
| Exhibit       | ​ | Description |
| 1.1           | ​ | Underwriting Agreement, dated December 2, 2021, by and between the Registrant and Needham & Company LLC (incorporated by reference to Exhibit 1.1 to the Current Report on Form 8-K filed with the                Securities & Exchange Commission on December 8, 2021) |
| 3.4           | ​ | Amended and Restated Memorandum and Articles of Association (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on December 8, 2021) |
| 4.1           | ​ | Specimen Unit Certificate (incorporated by reference to Exhibit 4.1 to Registration Statement on Form S-1 filed with the Securities & Exchange Commission on November 19, 2021) |
| 4.2           | ​ | Specimen Ordinary Share Certificate (incorporated by reference to Exhibit 4.2 to Registration Statement on Form S-1 filed with the Securities & Exchange Commission on November 19, 2021) |
| 4.3           | ​ | Specimen Warrant Certificate (incorporated by reference to Exhibit 4.3 to Registration Statement on Form S-1 filed with the Securities & Exchange Commission on November 19, 2021) |
| 4.4           | ​ | Warrant Agreement, dated December 2, 2021, among the Registrant and Continental Stock Transfer & Trust Company, as warrant agent (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K                filed with the Securities & Exchange Commission on December 8, 2021) |
| 4.5*          |   | Description of Securities |
| 10.1          | ​ | Letter Agreement dated December 2, 2021, among the Registrant, Blue Ocean Sponsor LLC, Apollo SPAC Fund I, L.P., and the Registrant’s officers and directors (incorporated by reference to Exhibit 10.1 to the                Current Report on Form 8-K filed with the Securities & Exchange Commission on December 8, 2021) |
| 10.3          | ​ | Investment Management Trust Agreement dated December 2, 2021, between the Registrant and Continental Stock Transfer & Trust Company, as trustee (incorporated by reference to Exhibit 10.2 to the Current                Report on Form 8-K filed with the Securities & Exchange Commission on December 8, 2021) |
| 10.4          | ​ | Registration Rights Agreement, dated December 2, 2021, among the Registrant, Blue Ocean Sponsor LLC and certain other security holders named therein (incorporated by reference to Exhibit 10.3 to the Current                Report on Form 8-K filed with the Securities & Exchange Commission on December 8, 2021) |
| 10.6          | ​ | Private Placement Warrants Purchase Agreement, dated December 2, 2021, between the Registrant and Blue Ocean Sponsor LLC (incorporated by reference to Exhibit 10.4 to the Current Report on Form 8-K filed with                the Securities & Exchange Commission on December 8, 2021) |
| 10.7          |   | Form of Indemnity Agreement, dated December 2, 2021, between the Company and each officer and/or director (incorporated by reference to Exhibit 10.6                to the Current Report on Form 8-K, filed with the Securities & Exchange Commission on December 8, 2021) |
| 10.8          | ​ | Securities Subscription Agreement, dated as of April 6, 2021, between the Registrant and Blue Ocean Sponsor LLC (incorporated by reference to Exhibit 10.8 to Registration Statement on Form S-1 filed with the                Securities & Exchange Commission on November 9, 2021) |
| 10.9          | ​ | Securities Subscription Agreement, dated as of October 28, 2021, by and among the Registrant, Blue Ocean Sponsor LLC and Apollo SPAC Fund I, L.P. (incorporated by reference to Exhibit 10.9 to Registration                Statement on Form S-1 filed with the Securities & Exchange Commission on November 9, 2021) |
| 10.10         | ​ | Administrative Support Agreement, dated December 2, 2021, between the Registrant and Blue Ocean Sponsor LLC (incorporated by reference to Exhibit 10.5 to the Current Report on Form 8-K filed with the                Securities & Exchange Commission on December 8, 2021) |
| 14.1          | ​ | Form of Code of Ethics (incorporated by reference to Exhibit 14.1 to Registration Statement on Form S-1 filed with the Securities & Exchange Commission on November 19, 2021) |
| 31.1*         |   | Certification of the Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes Oxley Act of                2002. |

----

 Table of Contents

| 31.2*    |    | Certification of the Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes Oxley Act of                2002. |
|----------|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 32.1**   |    | Certification of the Chief Executive Officer Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002                                                                                         |
| 32.2**   | ​ | Certification of the Chief Financial Officer Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002                                                                                         |
| 99.1     | ​ | Form of Audit Committee Charter (incorporated by reference to Exhibit 99.1 to Registration Statement on Form S-1 filed with the Securities & Exchange Commission on November 19, 2021)                                            |
| 99.2     | ​ | Form of Compensation Committee Charter (incorporated by reference to Exhibit 99.2 to Registration Statement on Form S-1 filed with the Securities & Exchange Commission on November 19, 2021)                                     |
| 101.INS* |         | Inline XBRL Instance Document.                                                                                                                                                                                                        |
| 101.SCH* |         | Inline XBRL Taxonomy Extension Schema.                                                                                                                                                                                                |
| 101.CAL* |         | Inline XBRL Taxonomy Calculation Linkbase.                                                                                                                                                                                            |
| 101.LAB* |         | Inline XBRL Taxonomy Label Document.                                                                                                                                                                                                  |
| 101.PRE* |         | Inline XBRL Definition Linkbase Document.                                                                                                                                                                                             |
| 101.DEF* |         | Inline XBRL Definition Linkbase Document.                                                                                                                                                                                             |
| 104*     |         | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).                                                                                                                                             |

| Item 16. | Form 10-K Summary. |
|----------|--------------------|

----

 Table of Contents

|                                                                                                                         | Page |
|------------------------------------------------------------------------------------------------------------------------------|------|
| Report of Independent Registered Public Accounting Firm (PCAOB ID #688)                                                      | F-2  |
| Balance Sheet                                                                                                                | F-3  |
| Statement of Operations for the period from March 26, 2021 (inception) through December 31, 2021                             | F-4  |
| Statement of Changes in Shareholders’ Deficit for the period from March 26, 2021 (inception) through December 31, 2021 | F-5  |
| Statement of Cash Flows for the period from March 26, 2021 (inception) through December 31, 2021                             | F-6  |
| Notes to Financial Statement                                                                                                 | F-7  |

----

 Table of Contents

----

 Table of Contents

| Assets                                                                                                                                                                  |   |   |        |   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------|-------------|--------|
| Current Assets:                                                                                                                                                         |   |   |        |   |
| Cash                                                                                                                                                                    |   | $      | 1,050,670   |   |
| Prepaid expenses and other assets                                                                                                                                       |   |   | 285,020     |   |
| Total current assets                                                                                                                                                    |   |   | 1,335,690   |   |
| Non-current assets                                                                                                                                                      |   |   |        |   |
| Other assets                                                                                                                                                            |   |   | 236,041     |   |
| Marketable securities in trust account                                                                                                                                  |   |   | 193,549,933 |   |
| Total assets                                                                                                                                                            |   | $      | 195,121,664 |   |
| Liabilities and Shareholders’ Deficit                                                                                                                             |   |   |        |   |
| Current Liabilities:                                                                                                                                                    |   |   |        |   |
| Accounts payable and accrued expenses                                                                                                                                   |   | $      | 139,852     |   |
| Accrued offering costs                                                                                                                                                  |   |   | 11,105      |   |
| Total current liabilities                                                                                                                                               |   |   | 150,957     |   |
| Accrued offering costs, non-current                                                                                                                                     |   |   | 806,823     |   |
| Warrant liabilities                                                                                                                                                     |   |   | 12,629,625  |   |
| Deferred underwriting fee payable                                                                                                                                       |   |   | 6,641,250   |   |
| Total liabilities                                                                                                                                                       |   |   | 20,228,655  |   |
|                                                                                                                                                                    |   |
| Commitments                                                                                                                                                             |   |   |        |   |
| Class A ordinary shares subject to possible redemption, 18,975,000 shares issued and outstanding at redemption value at $10.20 per share                                |   |   | 193,545,000 |   |
|                                                                                                                                                                    |   |
| Shareholders’ Deficit:                                                                                                                                            |   |   |        |   |
| Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none outstanding                                                                                      |   |   |        |   |
| Class A ordinary shares, $0.0001 Par Value; 200,000,000 shares authorized; no shares issued or outstanding (excluding 18,975,000 shares subject to possible redemption) |   |   | —     |   |
| Class B ordinary shares, $0.0001 Par Value; 20,000,000 shares authorized; 4,743,750 shares issued and outstanding(1)                                                    |   |   | 474         |   |
| Additional paid-in capital                                                                                                                                              |   |   | —     |   |
| Accumulated deficit                                                                                                                                                     |   |   | (18,652,465 | )      |
| Total shareholders’ deficit                                                                                                                                       |   |   | (18,651,991 | )      |
| Total Liabilities and Shareholders’ Deficit                                                                                                                       |   | $      | 195,121,664 |   |

----

 Table of Contents

| Formation and general and administrative expenses                                              |   | $      | 214,079   |   |
|------------------------------------------------------------------------------------------------|--------|--------|-----------|--------|
| Loss from operations                                                                           |   |   | (214,079  | )      |
| Other Income (expense):                                                                        |   |   |      |   |
| Interest earned on marketable securities held in Trust Account                                 |   |   | 4,933     |   |
| Transaction costs allocable to warrant liabilities                                             |   |   | (480,506  | )      |
| Change in fair value of warrant liabilities                                                    |   |   | 2,432,625 |   |
| Net income                                                                                     |   | $      | 1,742,973 |   |
| Weighted average shares outstanding of Class A redeemable ordinary shares                      |   |   | 1,608,750 |   |
| Basic and diluted net income per ordinary share, Class A redeemable ordinary shares            |   | $      | 0.30      |   |
| Weighted average shares outstanding of Class B ordinary shares non-redeemable shares           |   |   | 4,173,616 |   |
| Basic and diluted net income per ordinary share, Class B ordinary shares non-redeemable shares |   | $      | 0.30      |   |

----

 Table of Contents

|                                                    |   | Class B         |      |   | Additional |   |    |        |   |   | Total               |   |
|---------------------------------------------------------|--------|-----------------|-----------|--------|------------|--------|---------|-------------|--------|--------|---------------------|--------|
|                                                    |   | Ordinary shares |      |   | Paid in    |   |    | Accumulated |   |   | Shareholders’ |   |
|                                                    |   | Shares          |      |   | Amount     |   |    | Capital     |   |   | Deficit             |   |   | Equity (Deficit) |   |
| Balance – March 26, 2021 (Date of Inception)      |   |            | —   |   |       | $      | — |        |   | $      | —             |   |   | $ | — |   |   | $ | — |   |
| Issuance of Class B ordinary shares to Sponsor          |   |            | 4,743,750 |   |       |   | 474     |        |   |   | 24,526              |   |   |   | — |   |   |   | 25,000 |   |
| Forfeiture of Class B ordinary shares from Sponsor      |   |            | (175,000  | )      |       |   | (18     | )           |   |   | 18                  |   |   |   | — |   |   |   | — |   |
| Sale of Class B ordinary shares to Anchor investor      |   |            | 175,000   |   |       |   | 18      |        |   |   | 997                 |   |   |   | — |   |   |   | 1,015 |   |
| Excess of cash received from private placement warrants |   |            | —   |   |       |   | — |        |   |   | 1,752,750           |   |   |   | — |   |   |   | 1,752,750 |   |
| Class A ordinary shares accretion to redemption value   |   |            | —   |   |       |   | — |        |   |   | (1,778,291          | )      |   |   | (20,395,438 | ) |   |   | (22,173,729 | ) |
| Net Income                                              |   |            | —   |   |       |   | — |        |   |   | —             |   |   |   | 1,742,973 |   |   |   | 1,742,973 |   |
| Balance – December 31, 2021                       |   |            | 4,743,750 |   |       | $      | 474     |        |   | $      | —             |   |   | $ | (18,652,465 | ) |   | $ | (18,651,991 | ) |

----

 Table of Contents

| Cash Flow from Operating Activities:                                                                               |   |   |         |
|--------------------------------------------------------------------------------------------------------------------|--------|--------|--------------|
| Net income                                                                                                         |   | $      | 1,742,973    |   |
| Adjustments to reconcile net income to net cash used in operating activities:                                      |   |   |         |   |
| Interest earned in Trust Account                                                                                   |   |   | (4,933       | ) |
| Change in fair value of warrant liabilities                                                                        |   |   | (2,432,625   | ) |
| Transaction costs allocated to warrant liabilities                                                                 |   |   | 480,506      |   |
| Changes in operating assets and liabilities:                                                                       |   |   |         |   |
| Prepaid expenses and other current assets                                                                          |   |   | (285,020     | ) |
| Other assets, non-current                                                                                          |   |   | (236,041     | ) |
| Accounts payable and accrued expenses                                                                              |   |   | 139,852      |   |
| Net cash used in operating activities                                                                              |   |   | (595,288     | ) |
| Cash flow from investing activities:                                                                               |   |   |         |   |
| Investment of cash in Trust Account                                                                                |   |   | (193,545,000 | ) |
| Net cash used in investing activities                                                                              |   |   | (193,545,000 | ) |
| Cash flows from financing activities:                                                                              |   |   |         |   |
| Proceeds from sale of Class A ordinary shares; net of underwriting discounts paid                                  |   |   | 186,505,000  |   |
| Proceeds from sale of private placement warrants                                                                   |   |   | 9,225,000    |   |
| Proceeds from issuance of Class B ordinary shares to initial shareholder                                           |   |   | 25,000       |   |
| Proceeds from issuance of Class B ordinary shares to anchor investor                                               |   |   | 1,015        |   |
| Proceeds from promissory note                                                                                      |   |   | 165,340      |   |
| Paydown of promissory note                                                                                         |   |   | (165,340     | ) |
| Payment of offering costs                                                                                          |   |   | (565,057     | ) |
| Net cash provided by financing activities                                                                          |   |   | 195,190,958  |   |
| Net change in cash                                                                                                 |   |   | 1,050,670    |   |
| Cash at the beginning of the period                                                                                |   |   | —      |   |
| Cash at the end of the period                                                                                      |   | $      | 1,050,670    |   |
| Supplemental Disclosure of Non-Cash Investing and Financing Activities:                                            |   |   |         |   |
| Offering costs included in accrued expenses                                                                        |   | $      | 817,928      |   |
| Deferred underwriting fee payable                                                                                  |   | $      | 6,641,250    |   |
| Initial measurement of warrants issued in connection with the initial public offering accounted for as liabilities |   | $      | 15,062,250   |   |
| Accretion of ordinary shares subject to redemption                                                                 |   | $      | 22,173,729   |   |

----

 Table of Contents

| NOTE 1. | DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS |
|---------|-----------------------------------------------------|

----

 Table of Contents

| NOTE 1. | DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS(cont.) |
|---------|------------------------------------------------------------|

----

 Table of Contents

| NOTE 1. | DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS(cont.) |
|---------|------------------------------------------------------------|

----

 Table of Contents

| NOTE 2. | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
|---------|--------------------------------------------|

----

 Table of Contents

| NOTE 2. | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES(cont.) |
|---------|---------------------------------------------------|

| Level 1: | Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and              volume to provide pricing information on an ongoing basis. |
|----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Level 2: | Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets              that are not active. |
|----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Level 3: | Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. |
|----------|--------------------------------------------------------------------------------------------------------------------------------------|

----

 Table of Contents

| NOTE 2. | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES(cont.) |
|---------|---------------------------------------------------|

----

 Table of Contents

|                                                   |   | December 31, 2021 |        |
|--------------------------------------------------------|--------|-------------------|-------------|
| Gross proceeds                                         |   | $                 | 187,750,000 |   |
| Less:                                                  |   |              |        |   |
| Proceeds allocated to Public Warrants                  |   |              | (7,590,000  | ) |
| Class A ordinary shares issuance costs                 |   |              | (10,788,729 | ) |
| Plus:                                                  |   |              |        |   |
| Adjust carrying value to initial redemption value      |   |              | 22,173,729  |   |
| Class A ordinary shares subject to possible redemption |   | $                 | 193,545,000 |   |
|                                                           | For the Period fromMarch 26, 2021 (Date of Inception) throughDecember 31, 2021 |   |
|----------------------------------------------------------------|--------------------------------------------------------------------------------|--------|
|                                                           | Class A                                                                        |   | Class B |   |
| Basic and diluted net income per share                         |                                                                           |   |   |   |
| Numerator:                                                     |                                                                           |   |   |   |
| Allocation of net income, as adjusted                          |                                                                           | $      | 484,924 |   |   | $ | 1,258,049 |   |
| Denominator:                                                   |                                                                           |   |   |   |   |   |   |   |
| Basic and diluted weighted average ordinary shares outstanding |                                                                           |   | 1,608,750 |   |   |   | 4,173,616 |   |
| Basic and diluted net income per ordinary share                |                                                                           | $      | 0.30 |   |   | $ | 0.30 |   |

----

 Table of Contents

| NOTE 2. | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES(cont.) |
|---------|---------------------------------------------------|

| NOTE 3. | PUBLIC OFFERING |
|---------|-----------------|

| NOTE 4. | PRIVATE PLACEMENT |
|---------|-------------------|

| NOTE 5. | RELATED PARTY TRANSACTIONS |
|---------|----------------------------|

----

 Table of Contents

| NOTE 5. | RELATED PARTY TRANSACTIONS(cont.) |
|---------|-----------------------------------|

----

 Table of Contents

| NOTE 5. | RELATED PARTY TRANSACTIONS(cont.) |
|---------|-----------------------------------|

| NOTE 6. | COMMITMENTS AND CONTINGENCIES |
|---------|-------------------------------|

| NOTE 7. | WARRANTS |
|---------|----------|

----

 Table of Contents

| NOTE 7. | WARRANTS(cont.) |
|---------|-----------------|

| • | in whole and not in part; |
|---------|---------------------------|
| • | at a price of $0.01 per Public Warrant; |
|---------|-----------------------------------------|
| • | upon not less than 30 days’ prior written notice of redemption to each warrant holder and |
|---------|-------------------------------------------------------------------------------------------------|
| • | if, and only if, the reported last sale price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price              of a warrant as described) for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders. |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | in whole and not in part; |
|---------|---------------------------|
| • | at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number              of shares determined by reference to the table based on the redemption date and the “fair market value” of our Class A ordinary shares; |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | if, and only if, the Reference Value (as defined above under “Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00”) equals or exceeds $10.00 per share (as adjusted for              adjustments to the number of shares issuable upon exercise or the exercise price of a warrant); and |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | if the Reference Value is less than $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant), the private placement warrants must also              concurrently be called for redemption on the same terms as the outstanding public warrants, as described above. |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

 Table of Contents

| NOTE 7. | WARRANTS(cont.) |
|---------|-----------------|

----

 Table of Contents

| NOTE 8. | SHAREHOLDER’S EQUITY |
|---------|----------------------------|

| NOTE 9. | FAIR VALUE MEASUREMENTS |
|---------|-------------------------|

|                                                   | December 31,2021 |   | QuotedPrices InActiveMarkets(Level 1) |   | SignificantOtherObservableInputs(Level 2) |   | SignificantOtherUnobservableInputs(Level 3) |   |
|--------------------------------------------------------|------------------|--------|---------------------------------------|--------|-------------------------------------------|--------|---------------------------------------------|--------|
|                                                   |             |   |                                  |   |                                      |   |                                        |   |
| Assets:                                                |             |   |                                  |   |                                      |   |                                        |   |
| Marketable securities held in Trust Account            |             | $      | 193,549,933                           |   |                                      | $      | 193,549,933                                 |   |   | $ | — |   |   | $ | — |   |
| Liabilities:                                           |             |   |                                  |   |                                      |   |                                        |   |   |   |   |   |   |   |   |   |
| Warrant liabilities – Public Warrants            |             | $      | 6,356,625                             |   |                                      | $      | —                                     |   |   | $ | — |   |   | $ | 6,356,625 |   |
| Warrant liabilities – Private Placement Warrants |             | $      | 6,273,000                             |   |                                      | $      | —                                     |   |   | $ | — |   |   | $ | 6,273,000 |   |

----

 Table of Contents

| Input                                 |   | December 7,2021 |   |   | December 31,2021 |   |
|---------------------------------------|--------|-----------------|--------|--------|------------------|--------|
| Risk-free interest rate               |   |            | 0.86   | %      |             |   | 1.28 | % |
| Expected term (years)                 |   |            | 5.00   |   |             |   | 5.20 |   |
| Expected volatility                   |   |            | 15.43  | %      |             |   | 12.40 | % |
| Exercise price                        |   | $               | 11.50  |   |             | $      | 11.50 |   |
| Fair value of Class A ordinary shares |   | $               | 9.60   |   |             | $      | 9.66 |   |

|  | • | The risk-free interest rate assumption was based on the U.S. Treasury Constant Maturity rate for the expected term of the warrants. |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------|
|  | • | The expected term was determined utilizing a probability weighted term input to be consistent with the stock price and volatility inputs which are reflective of the probability of successful merger. |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | The expected volatility assumption was based on the implied volatility solved by calibrating the warrant value output from a Binomial Lattice based model  to the publicly observed, traded price on each              valuation date. An increase in the expected volatility, in isolation, would result in an increase in the fair value measurement of the warrant liabilities and vice versa. |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | The fair value of one Class A ordinary share is inferred by solving to the publicly-traded stock price. |
|--|---------|---------------------------------------------------------------------------------------------------------|
| Derivative warrant liabilities at March 26, 2021 (inception) |   | $      | -          |   |
|--------------------------------------------------------------|--------|--------|------------|--------|
| Issuance of Public and Private Warrants                      |   |   | 13,270,360 |   |
| Issuance of Public and Private Warrants - over-allotment     |   |   | 1,791,900  |   |
| Change in fair value of derivative warrant liabilities       |   |   | (2,432,625 | )      |
| Derivative warrant liabilities at December 31, 2021          |   | $      | 12,629,625 |   |

| NOTE 10. | SUBSEQUENT EVENTS |
|----------|-------------------|

----

 Table of Contents

| March 29, 2022 | Blue Ocean Acquisition Corp |
|----------------|-----------------------------|
|           |                        |
|           | By:                         | /s/ Paul Bascobert |
|           |                             | Name: Paul Bascobert |
|           |                             | Title: Chief Executive Officer |
| Signature             |   | Title                                                               |   | Date           |
|-----------------------|--------|---------------------------------------------------------------------|--------|----------------|
|                  |   |                                                                |   |           |
| /s/ Marcus Brauchli   |   | Chairman                                                            |   | March 29, 2022 |
| Marcus Brauchli       |   |                                                                |
|                  |   |                                                                |   |           |
| /s/ Paul Bascobert    |   | Chief Executive Officer(Principal Executive Officer)                |   | March 29, 2022 |
| Paul Bascobert        |   |                                                                |
|                  |   |                                                                |   |           |
| /s/ Ankur Manglik     |   | Chief Financial Officer(Principal Financial and Accounting Officer) |   | March 29, 2022 |
| Ankur Manglik         |   |                                                                |
|                  |   |                                                                |   |           |
| /s/ Norman Pearlstine |   | Director                                                            |   | March 29, 2022 |
| Norman Pearlstine     |   |                                                                |
|                  |   |                                                                |   |           |
| /s/ Joel Motley       |   | Director                                                            |   | March 29, 2022 |
| Joel Motley           |   |                                                                |
|                  |   |                                                                |   |           |
| /s/ Matt Goldberg     |   | Director                                                            |   | March 29, 2022 |
| Matt Goldberg         |   |                                                                |
| /s/ Priscilla Han |   | Director |   | March 29, 2022 |
|-------------------|--------|----------|--------|----------------|
| Priscilla Han     |   |     |
|              |   |     |   |           |
| /s/ Dale Mathias  |   | Director |   | March 29, 2022 |
| Dale Mathias      |   |     |
|              |   |     |   |           |
| /s/ Sean Glodek   |   | Director |   | March 29, 2022 |
| Sean Glodek       |   |     |

----